PROFILE

YOKOMIZO Takehiko, M.D., Ph.D.


Department of Molecular and Cellular Biochemistry

Short Biography

1988
M.D. The University of Tokyo Faculty of Medicine
1995
Ph.D. The University of Tokyo Graduate School of Medicine
1995-1998
Postdoctoral Fellow (JSPS Fellow), The University of Tokyo
1998
Research Associate, The University of Tokyo
2000
Associate Professor, The University of Tokyo
2006
Professor, Kyushu University
2012
Professor, Department of Molecular and Cellular Biochemistry, Juntendo University Faculty of Medicine
 

Main Research Topics and Interests

  • Lipid mediators (Leukotriene, Prostaglandin)
  • G-protein coupled receptor
  • Signal transduction
  • Immune response
  • Knockout mice

Publications (in English)

  • Original Articles (89)
  • Review Articles (24)
  • Books (25)
  • Total Citations (8,238)
  • Average Citations (59.7)

Recent Main Publications

  • Ichiki T, Koga T, Okuno T, Saeki K, Yamamoto Y, Yamamoto H, Sakaguchi M, Yokomizo T. 2016. Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE). FASEB J 30: 1811-22
  • Ishii Y, Saeki K, Liu M, Sasaki F, Koga T, Kitajima K, Meno C, Okuno T, Yokomizo T. 2016. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins. FASEB J 30: 933-47
  • Okuno T, Ishitani T, Yokomizo T. 2015. Biochemical Characterization of Three BLT Receptors in Zebrafish. PLoS One 10: e0117888
  • Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, Yokoyama C, Nakamizo S, Kabashima K, Narumiya S, Shimizu T, Yokomizo T*: 12-hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med, 2014; 211: 1063-78
  • More

Other Specific Comments

  • Prof. Yokomizo is famous for his cloning of leukotriene B4 receptors (Nature 1997 and JEM 2000). He is a leader of lipid research in Japan, and mainly working on GPCRs on lipid mediators using biochemistry, immunology and gene targeting. English-speaking ability is required.

Link